Cargando…

Targeting Streptomyces-Derived Streptenol Derivatives against Gynecological Cancer Target PIK3CA: An In Silico Approach

Streptomyces is amongst the most amenable genera for biotechnological applications, and it is extensively used as a scaffold for drug development. One of the most effective therapeutic applications in the treatment of cancer is targeted therapy. Small molecule therapy is one of them, and it has gott...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jemmy Christy, H., Vasudevan, Swetha, Sudha, S., Kandeel, Mahmoud, Subramanian, Kumaran, Pugazhvendan, S. R., Ronald Ross, P., Velmurugan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293527/ https://www.ncbi.nlm.nih.gov/pubmed/35860806 http://dx.doi.org/10.1155/2022/6600403

Ejemplares similares

Risk assessment studies on HLA association with drug induced hypersensitivity caused by anti tuberculosis drugs – an in silico approach
por: Saxena, Prashant, et al.
Publicado: (2014)

Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA
por: Chandran, Smita S., et al.
Publicado: (2022)

Study of Imidazolium Salt Derivatives as PIK3CA Inhibitors Using a Comprehensive in Silico Method
por: Wang, Ming-yang, et al.
Publicado: (2018)

Antimalarial Properties of Isoquinoline Derivative from Streptomyces hygroscopicus subsp. Hygroscopicus: An In Silico Approach
por: Nugraha, Rivo YB., et al.
Publicado: (2020)

Targeting glutamine metabolism in PIK3CA mutant colorectal cancers
por: Feng, Xiujing, et al.
Publicado: (2016)

PIK3CA dependence and sensitivity to therapeutic targeting in urothelial carcinoma
por: Ross, R. L., et al.
Publicado: (2016)

Bioconversion of chitin waste through Stenotrophomonas maltophilia for production of chitin derivatives as a Seabass enrichment diet
por: Subramanian, Kumaran, et al.
Publicado: (2022)

Preparation of an Intelligent pH Film Based on Biodegradable Polymers for Monitoring the Food Quality and Reducing the Microbial Contaminants
por: Subramanian, Kumaran, et al.
Publicado: (2022)

Dual CCNE1/PIK3CA targeting is synergistic in CCNE1-amplified/PIK3CA-mutated uterine serous carcinomas in vitro and in vivo
por: Cocco, Emiliano, et al.
Publicado: (2016)

Metabolic Fingerprinting Links Oncogenic PIK3CA with Enhanced Arachidonic Acid-Derived Eicosanoids
por: Koundouros, Nikos, et al.
Publicado: (2020)

In silico design and synthesis of targeted rutin derivatives as xanthine oxidase inhibitors
por: Malik, Neelam, et al.
Publicado: (2019)

Biology and Targetability of the Extended Spectrum of PIK3CA Mutations Detected in Breast Carcinoma
por: Rugo, Hope S., et al.
Publicado: (2023)

Artemisinin Derivatives Target Topoisomerase 1 and Cause DNA Damage in Silico and in Vitro
por: Kadioglu, Onat, et al.
Publicado: (2017)

Differential MMP-14 Targeting by Lumican-Derived Peptides Unraveled by In Silico Approach
por: Dauvé, Jonathan, et al.
Publicado: (2021)

Adamantane-derived scaffolds targeting the sigma-2 receptor; an in vitro and in silico study
por: Alamri, Mohammed A., et al.
Publicado: (2021)

Carcinogenesis of PIK3CA
por: German, Sidra, et al.
Publicado: (2013)

Targeted Isolation of N-Acetylcysteine-Containing Angucycline Derivatives from Streptomyces sp. MC16 and Their Antiproliferative Effects
por: Kim, Jun Gu, et al.
Publicado: (2023)

Analysis of the HIV resistance related HLA dRB1 restricted CD4+ T cell epitopes among Indian HIV patients
por: Christy, H Jemmy, et al.
Publicado: (2014)

PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors
por: Payne, S N, et al.
Publicado: (2015)

Targeting the mutant PIK3CA gene by DNA‐alkylating pyrrole‐imidazole polyamide in cervical cancer
por: Krishnamurthy, Sakthisri, et al.
Publicado: (2021)

Targeting PIK3CA Actionable Mutations in the Circulome: A Proof of Concept in Metastatic Breast Cancer
por: Cardinali, Barbara, et al.
Publicado: (2022)

Targeting p85β nuclear translocation for the tumors with PIK3CA helical domain mutations
por: He, Baoyu, et al.
Publicado: (2022)

Bioactive Diketopiperazines and Nucleoside Derivatives from a Sponge-Derived Streptomyces Species
por: Shaala, Lamiaa A., et al.
Publicado: (2019)

Combined Antiangiogenic and Mammalian Target of Rapamycin Inhibitor Targeted Therapy in Metaplastic Breast Cancer Harboring a PIK3CA Mutation
por: Agarwal, Rishi, et al.
Publicado: (2014)

PIK3CA in Colorectal Cancer
por: Cathomas, Gieri
Publicado: (2014)

An Antibody‐Tumor Model for the Targeting of CA125‐producing Gynecologic Malignancies
por: Saga, Tsuneo, et al.
Publicado: (1990)

Isolation of anticancer bioactive secondary metabolites from the sponge-derived endophytic fungi Penicillium sp. and in-silico computational docking approach
por: Kaliaperumal, Kumaravel, et al.
Publicado: (2023)

Structure and Evolution of Streptomyces Interaction Networks in Soil and In Silico
por: Vetsigian, Kalin, et al.
Publicado: (2011)

Diketopiperazine Derivatives from the Marine-Derived Actinomycete Streptomyces sp. FXJ7.328
por: Wang, Pei, et al.
Publicado: (2013)

Comparison of targeted next-generation sequencing and Sanger sequencing for the detection of PIK3CA mutations in breast cancer
por: Arsenic, Ruza, et al.
Publicado: (2015)

Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations
por: Moon, Jai-Hee, et al.
Publicado: (2019)

Function of miR-152 as a Tumor Suppressor in Human Breast Cancer by Targeting PIK3CA
por: Ge, Shuke, et al.
Publicado: (2017)

PIK3CA Mutation Is Associated with Poor Response to HER2-Targeted Therapy in Breast Cancer Patients
por: Kim, Ju Won, et al.
Publicado: (2023)

The quest for the optimal biomarker: is extending the spectrum of targeted PIK3CA mutations in breast cancer carcinoma worthwhile?
por: Quesada, Stanislas, et al.
Publicado: (2023)

Mechanism Exploration of Arylpiperazine Derivatives Targeting the 5-HT(2A) Receptor by In Silico Methods
por: Lin, Feng, et al.
Publicado: (2017)

A Theobromine Derivative with Anticancer Properties Targeting VEGFR‐2: Semisynthesis, in silico and in vitro Studies
por: Eissa, Ibrahim H., et al.
Publicado: (2023)

Comprehensive in silico analyses of flavonoids elucidating the drug properties against kidney disease by targeting AIM2
por: Kandeel, Mahmoud, et al.
Publicado: (2023)

Antitubercular, Cytotoxicity, and Computational Target Validation of Dihydroquinazolinone Derivatives
por: Venugopala, Katharigatta N., et al.
Publicado: (2022)

The way to precision medicine in gynecologic cancers: The first case report of an exceptional response to alpelisib in a PIK3CA-mutated endometrial cancer
por: Passarelli, Anna, et al.
Publicado: (2023)

Mutations of PIK3CA in gastric adenocarcinoma
por: Li, Vivian Sze Wing, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_69eejcjhkmu2dvv9kivlfo60vo